Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study - Scorecard - MDSpire

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

  • By

  • Ma Wanda

  • Lei Mengjie

  • Wang Jingyao

  • Sun Xue

  • Wang Xiao

  • Li Cairong

  • Li Yachao

  • Zhao Zhigang

  • Xue Zengming

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Long-term Single Antiplatelet Therapy Outcomes in High-Risk Acute Coronary Syndrome Patients: A Precision Cohort Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsThrombosis due to platelet activation and thrombin production; clarify relation to antiplatelet therapy.
Target Population
Care Setting

Key Highlights

  • highlight

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • g
    • u
    • i
    • d
    • e
    • l
    • i
    • n
    • e
    • r
    • e
    • f
    • e
    • r
    • e
    • n
    • c
    • e
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        High-risk ACS patients post-PCI.

        Clopidogrel may be preferred over aspirin for SAPT in this population.

        Clinical Best Practices

        • best_practice

        References

        Original Source(s)

        Related Content